Azithromycin Cas nambarka: 83905-01-5 Formula Molecular: C38H72N2O12

Alaabta

Azithromycin Cas nambarka: 83905-01-5 Formula Molecular: C38H72N2O12

Sharaxaad Gaaban:

Lambarka Cas: 83905-01-5

Magaca Kiimikada:Azithromycin

Qaacidada Molecular:C38H72N2O12

La mid ah: (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L- ribo-hexopyranosyl) oxy] -2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[3,4,6-trideoxy-3-( dimethylamino) -β-D-xylo-hexopyranosyl] oxy] -1-oxa-6-azacyclopentadecan-15-hal


Faahfaahinta Alaabta

Tags Product

Tilmaamaha Alaabta

Meesha dhalaalaysa 115°C
Cufnaanta 1.18 g/cm³
heerkulka kaydinta Jawi aan firfircoonayn, heerkulka qolka 2-8°C
milmayn DMF: 16 ​​mg/ml DMSO: 5 mg/mlm Ethanol: 16 mg/ml ethanol:PBS(pH 7.2) (1:1): 0.50 mg/ml
dhaqdhaqaaqa indhaha  N/A
Muuqashada Budada Cad
daahirnimo ≥98%

Sharaxaada

Manus Aktteva Biopharma LLP, oo ah shirkad caalami ah oo wax ka soo saarta iyo alaab-qeybiyaha Azithromycin (CAS No.: 83905-01-5) waxay ku siinaysaa shuruudahaaga tirada RND/hormarinta ama xayaysiisyada, iyadoo ku saleysan heerka badeecada.

AFEEF: In kasta oo dadaalka saxda ah ee suurtogalka ah la samayn doono oo aanu ka wada shaqayn doono arrimaha oo dhan haddii wax dhibaato ahi timaado inta lagu jiro koorsada ilaha , nalama qaadi karo mas'uul ka ah wax kasta oo u hoggaansami la'aanta ama dhibaatooyinka macaamil ganacsi ee dhici kara, taas oo ka baxsan xakamayntayada. Qaybta/liiska jadwalka daawooyinka waa in si toos ah looga dhoofiyaa maamulayaasha soo saaraha ka hor inta aan la helin ogolaanshaha asalka ah ee soo dejinta ee ay bixiyaan mas'uuliyiinta ay khusayso ee dalka soo dejinta. sharciyada heer gobol ama caalami.Diiwaanadayada dadwaynaha waxay ka hadlaan kalsoonidayada.Ma dhiirigelino ama rabno inaan ka mid noqono ururada gaarka ah ama kuwa guud si loo caddeeyo u hoggaansanaantayada.

PATENTS Alaabooyinka lagu ilaaliyo shatiyada saxda ah laguma soo bandhigo iib wadamada ay iibinta alaabadaas ka kooban tahay jebinta patent mas'uuliyadeedana waxay ku jirtaa khatarta iibsadaha.Alaabooyinka hadda ay daboolayaan shatiyada Mareykanka ee ansaxa ah waxaa loo soo bandhigay isticmaalka R&D si waafaqsan 35 USC 271 +A13(1)•Manus Aktteva Biopharma LLP ma qaado mas'uuliyad/mas'uuliyad haddii la keeno alaab ku xad gudubta hantida garaadka si kasta ha ahaato oo ay ku jirto xuquuqda patent ee qof kasta.Manus Aktteva Biopharma LLP ma sameyso wax matalaad ama dammaanad ah nooc kasta, si cad ama si maldahan, oo ku saabsan asalka ama isku halaynta marka la eego hantida garaadka oo ay ku jirto shatiyada alaabteeda ama adeegyadeeda ujeedo kasta.Manus Aktteva Biopharma LLP waxa uu uga digayaa iibiyeyaasha in aanay iibin wax alaab ah oo ku xad-gudbinaya hantida aqooneed si kasta oo ay ku jirto xuquuqaha patentka ee qof kasta.Manus Aktteva Biopharma LLP waxa uu uga digayaa iibsadayaasha in aanay isticmaalin/ soo iibin wax alaab ah si ay u gaadhaan badeecad laga yaabo in ay si badheedh ah u keento ku xad-gudub hantida garaadka si kasta ha ahaato ee ay ku jirto xuquuqaha rukhsadda ee qof kasta.

isticmaalka iyo qiyaasta

Azithromycin waa semi-synthetic, giraan-ballaaran erythromycin oo ay soo saartay Beckmann dib u habeynta erythromycin oxime iyo hoos u dhigista ether-ka imine, oo ay ku xigto methylation dhimis.Azithromycin waxay ahayd tii ugu horreysay ee azalides waxaana loogu talagalay inay hagaajiso xasilloonida iyo nolosha nuska noolaha ee erythromycin A, iyo sidoo kale hagaajinta dhaqdhaqaaqa ka hortagga bakteeriyada Gram negative.Tan iyo markii la helay 1980 ee Djokic iyo la-shaqeeyayaasha, azithromycin waxay ku riyaaqday guulo daweyn oo la taaban karo.

CADEB

  • Hore:
  • Xiga:

  • Halkan ku qor fariintaada oo noo soo dir